{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:01:28Z","timestamp":1762459288299},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2015,5,11]],"date-time":"2015-05-11T00:00:00Z","timestamp":1431302400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0126955","type":"journal-article","created":{"date-parts":[[2015,5,11]],"date-time":"2015-05-11T18:19:49Z","timestamp":1431368389000},"page":"e0126955","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["Transmitted Drug Resistance Mutations in Antiretroviral-Na\u00efve Injection Drug Users with Chronic HIV-1 Infection in Iran"],"prefix":"10.1371","volume":"10","author":[{"given":"Arash","family":"Memarnejadian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahoo","family":"Menbari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Ali","family":"Mansouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rouhollah","family":"Vahabpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Reza","family":"Aghasadeghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehsan","family":"Mostafavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Abdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,5,11]]},"reference":[{"issue":"13","key":"ref1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators","volume":"338","author":"FJ Palella Jr.","year":"1998","journal-title":"N Engl J Med"},{"issue":"5","key":"ref2","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3855\/jidc.247","article-title":"The prevalence of resistance-associated mutations to protease and reverse transcriptase inhibitors in treatment-naive (HIV1)-infected individuals in Casablanca, Morocco","volume":"3","author":"K Bakhouch","year":"2009","journal-title":"J Infect Dev Ctries"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1086\/427212","article-title":"Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naive patients: implications for routine resistance screening before initiation of antiretroviral therapy","volume":"40","author":"RM Novak","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijantimicag.2003.06.005","article-title":"Conflicting interpretations of the prevalence of mutations associated with drug resistance in antiviral naive HIV-1 patients with acute and chronic infection","volume":"23","author":"MC Re","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2180-1-30","article-title":"Analysis of HIV-1 drug resistant mutations by line probe assay and direct sequencing in a cohort of therapy naive HIV-1 infected Italian patients","volume":"1","author":"MC Re","year":"2001","journal-title":"BMC Microbiol"},{"issue":"8","key":"ref6","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1258\/095646202760159684","article-title":"Low prevalence of antiretroviral resistance among persons recently infected with human immunodeficiency virus in two US cities","volume":"13","author":"PS Sullivan","year":"2002","journal-title":"Int J STD AIDS"},{"issue":"6","key":"ref7","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1086\/432916","article-title":"Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management","volume":"192","author":"AM Wensing","year":"2005","journal-title":"J Infect Dis"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/jmv.23452","article-title":"HIV-1 drug resistance-associated mutations among antiretroviral-naive Thai patients with chronic HIV-1 infection","volume":"85","author":"W Manosuthi","year":"2013","journal-title":"J Med Virol"},{"issue":"9","key":"ref9","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1089\/aid.2007.0072","article-title":"HIV-1 antiretroviral drug resistance in recently infected patients in Abidjan, Cote d'Ivoire: A 4-year survey, 2002\u20132006","volume":"23","author":"T Toni","year":"2007","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"Suppl 2","key":"ref10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/135965350801302S03","article-title":"The World Health Organization's global strategy for prevention and assessment of HIV drug resistance","volume":"13","author":"DE Bennett","year":"2008","journal-title":"Antivir Ther"},{"key":"ref11","article-title":"Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents","year":"2014"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/jama.2012.7961","article-title":"Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel","volume":"308","author":"MA Thompson","year":"2012","journal-title":"JAMA"},{"issue":"2","key":"ref13","first-page":"77","article-title":"European recommendations for the clinical use of HIV drug resistance testing: 2011 update","volume":"13","author":"AM Vandamme","year":"2011","journal-title":"AIDS Rev"},{"issue":"Suppl 2","key":"ref14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/135965350801302S04","article-title":"Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment","volume":"13","author":"DE Bennett","year":"2008","journal-title":"Antivir Ther"},{"key":"ref15","unstructured":"National AIDS Committee Secretariat MoHaME. Islamic Re-public of Iran AIDS Progress Report On Monitoring of the United Nations General Assembly Special Session (UNGASS) on HIV and AIDS. March 2014. Report No."},{"key":"ref16","article-title":"HIV prevalence and risk behaviours among people who inject drugs in Iran: the 2010 National Surveillance Survey","author":"R Khajehkazemi","year":"2013","journal-title":"Sex Transm Infect"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"e4724","DOI":"10.1371\/journal.pone.0004724","article-title":"Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update","volume":"4","author":"DE Bennett","year":"2009","journal-title":"PLoS One"},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","first-page":"e61864","DOI":"10.1371\/journal.pone.0061864","article-title":"Prevalence of transmitted HIV drug resistance in Iran between 2010 and 2011","volume":"8","author":"F Jahanbakhsh","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00705-009-0583-6","article-title":"Surveillance of HIV drug resistance transmission in Iran: experience gained from a pilot study","volume":"155","author":"SM Mousavi","year":"2010","journal-title":"Arch Virol"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/nar\/gkg100","article-title":"Human immunodeficiency virus reverse transcriptase and protease sequence database","volume":"31","author":"SY Rhee","year":"2003","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"ref21","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/jmv.23898","article-title":"Antiretroviral drug resistance among antiretroviral-naive and treatment experienced patients infected with HIV in Iran","volume":"86","author":"K Baesi","year":"2014","journal-title":"J Med Virol"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7883\/yoken.52.21","article-title":"Prevalence of drug resistance-related mutations among HIV-1s in Japan","volume":"52","author":"W Sugiura","year":"1999","journal-title":"Jpn J Infect Dis"},{"issue":"10","key":"ref23","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1093\/molbev\/msr121","article-title":"MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods","volume":"28","author":"K Tamura","year":"2011","journal-title":"Mol Biol Evol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.meegid.2013.04.032","article-title":"Automated subtyping of HIV-1 genetic sequences for clinical and surveillance purposes: performance evaluation of the new REGA version 3 and seven other tools","volume":"19","author":"AC Pineda-Pena","year":"2013","journal-title":"Infect Genet Evol"},{"issue":"Suppl 2","key":"ref25","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1097\/01.aids.0000386738.32919.67","article-title":"Assessing subtype and drug-resistance-associated mutations among antiretroviral-treated HIV-infected patients","volume":"24","author":"R Hamkar","year":"2010","journal-title":"AIDS"},{"issue":"6","key":"ref26","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1089\/aid.2006.0299","article-title":"A nascent HIV type 1 epidemic among injecting drug users in Kabul, Afghanistan is dominated by complex AD recombinant strain, CRF35_AD","volume":"23","author":"E Sanders-Buell","year":"2007","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/sti.2010.043711","article-title":"HIV-1 molecular epidemiology evidence and transmission patterns in the Middle East and North Africa","volume":"87","author":"G Mumtaz","year":"2011","journal-title":"Sex Transm Infect"},{"issue":"12","key":"ref28","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1089\/aid.2010.0324","article-title":"Antiretroviral drug resistance mutations among treated and treatment-naive patients in Pakistan: diversity of the HIV type 1 pol gene in Pakistan","volume":"27","author":"S Shah","year":"2011","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"7","key":"ref29","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/QAD.0b013e3282f5ff71","article-title":"Comparison of algorithms that interpret genotypic HIV-1 drug resistance to determine the prevalence of transmitted drug resistance","volume":"22","author":"L Liu","year":"2008","journal-title":"AIDS"},{"issue":"4","key":"ref30","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00002030-200203080-00014","article-title":"Low prevalence of primary mutations associated with drug resistance in antiviral-naive patients at therapy initiation","volume":"16","author":"CF Perno","year":"2002","journal-title":"AIDS"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"F17","DOI":"10.1097\/00002030-200001280-00003","article-title":"Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use. Investigators of the Quebec Primary Infection Study","volume":"14","author":"H Salomon","year":"2000","journal-title":"AIDS"},{"issue":"6","key":"ref32","doi-asserted-by":"crossref","first-page":"e62057","DOI":"10.1371\/journal.pone.0062057","article-title":"Comparisons of Primary HIV-1 Drug Resistance between Recent and Chronic HIV-1 Infection within a Sub-Regional Cohort of Asian Patients","volume":"8","author":"S Kiertiburanakul","year":"2013","journal-title":"PLoS One"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0126955","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T21:44:21Z","timestamp":1651959861000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0126955"}},"subtitle":[],"editor":[{"given":"Luis","family":"Men\u00e9ndez-Arias","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,5,11]]},"references-count":32,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,5,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0126955","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,11]]}}}